Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.81 - $3.43 $769,362 - $3.26 Million
949,830 Added 23.47%
4,996,565 $4.56 Million
Q1 2022

May 16, 2022

BUY
$2.27 - $4.13 $2.08 Million - $3.79 Million
917,136 Added 29.31%
4,046,735 $14 Million
Q4 2021

Feb 14, 2022

BUY
$3.37 - $6.87 $920,010 - $1.88 Million
273,000 Added 9.56%
3,129,599 $12.3 Million
Q2 2021

Aug 16, 2021

SELL
$7.82 - $12.44 $60,214 - $95,788
-7,700 Reduced 0.27%
2,856,599 $22.3 Million
Q1 2021

May 17, 2021

BUY
$9.33 - $14.05 $6.67 Million - $10 Million
715,242 Added 33.28%
2,864,299 $36.1 Million
Q2 2020

Aug 14, 2020

SELL
$12.28 - $17.63 $8.61 Million - $12.4 Million
-701,214 Reduced 24.6%
2,149,057 $29.6 Million
Q1 2020

May 15, 2020

SELL
$11.31 - $18.26 $5.75 Million - $9.28 Million
-508,061 Reduced 15.13%
2,850,271 $37.9 Million
Q4 2019

Feb 14, 2020

SELL
$6.44 - $14.21 $143,431 - $316,485
-22,272 Reduced 0.66%
3,358,332 $47 Million
Q3 2019

Nov 14, 2019

BUY
$4.6 - $8.46 $570,809 - $1.05 Million
124,089 Added 3.81%
3,380,604 $22.3 Million
Q2 2019

Aug 14, 2019

SELL
$5.83 - $8.42 $1.88 Million - $2.72 Million
-322,625 Reduced 9.01%
3,256,515 $27.2 Million
Q1 2019

May 15, 2019

BUY
$4.02 - $5.81 $863,170 - $1.25 Million
214,719 Added 6.38%
3,579,140 $20.8 Million
Q4 2018

Feb 14, 2019

BUY
$3.35 - $5.68 $1.93 Million - $3.28 Million
576,792 Added 20.69%
3,364,421 $13.6 Million
Q3 2018

Nov 14, 2018

BUY
$4.07 - $6.25 $8.54 Million - $13.1 Million
2,099,000 Added 304.81%
2,787,629 $15 Million
Q1 2018

May 07, 2018

SELL
$8.0 - $12.96 $284,024 - $460,118
-35,503 Reduced 4.9%
688,629 $5.51 Million
Q3 2017

Nov 14, 2017

BUY
$5.0 - $7.14 $3.62 Million - $5.17 Million
724,132
724,132 $5.05 Million

Others Institutions Holding MTEM

About Molecular Templates, Inc.


  • Ticker MTEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,351,600
  • Market Cap $7.33M
  • Description
  • Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...
More about MTEM
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.